This inventor holds 1 USPTO granted patent. Top assignee: Mitsubishi Pharma Corporation. Active years: 2007.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2007
Title: Eiji Kawahara: Innovator in Pharmaceutical Chemistry
Introduction
Eiji Kawahara is a notable inventor based in Suita, Japan. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds that have potential therapeutic applications.
Latest Patents
Kawahara holds a patent for Quinazoline derivatives. This compound, represented by the formula (I), or its pharmaceutically acceptable salts, hydrates, solvates, optically active compounds, racemates, or diastereomer mixtures, exhibits superior tyrosine-specific protein kinase inhibitory activity. It is particularly useful as a pharmaceutical agent for the prophylaxis or treatment of various cancers, psoriasis, and diseases caused by arteriosclerosis.
Career Highlights
Eiji Kawahara is associated with Mitsubishi Pharma Corporation, where he has been instrumental in advancing research and development in pharmaceutical innovations. His work has led to the creation of valuable compounds that address critical health issues.
Collaborations
Kawahara has collaborated with esteemed colleagues such as Yasunori Kitano and Tsuyoshi Suzuki. These partnerships have fostered a collaborative environment that enhances the research and development process.
Conclusion
Eiji Kawahara's contributions to pharmaceutical chemistry, particularly through his patent on Quinazoline derivatives, highlight his role as an innovator in the field. His work continues to impact the development of treatments for serious health conditions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile